Population pharmacokinetics/dynamics.

[1]  L B Sheiner,et al.  Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.

[2]  A W Kelman,et al.  Population Pharmacokinetics Theory and Clinical Application , 1986, Clinical pharmacokinetics.

[3]  C. Peck,et al.  Clinical pharmacodynamics of theophylline. , 1985, The Journal of allergy and clinical immunology.

[4]  A W Kelman,et al.  OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. , 1982, British journal of clinical pharmacology.

[5]  L. Sheiner,et al.  Study designs for dose‐ranging , 1989, Clinical pharmacology and therapeutics.

[6]  L B Sheiner,et al.  Population dose versus response of betaxolol and atenolol: A comparison of potency and variability , 1991, Clinical pharmacology and therapeutics.

[7]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[8]  M. Vasko,et al.  Comparison of Drug Dosing Methods , 1985, Clinical pharmacokinetics.

[9]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[10]  A. F. Smith,et al.  Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry , 1986 .

[11]  N Aoyagi,et al.  Application of the NONMEM method to evaluation of the bioavailability of drug products. , 1990, Journal of pharmaceutical sciences.

[12]  A Iliadis,et al.  Population pharmacokinetics of mitoxantrone performed by a NONMEM method. , 1989, Journal of pharmaceutical sciences.

[13]  A W Kelman,et al.  Population Analysis of the Pharmacokinetic Variability of High-Dose Metoclopramide in Cancer Patients , 1988, Clinical pharmacokinetics.

[14]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.

[15]  L B Sheiner,et al.  Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations. , 1975, Annals of internal medicine.

[16]  L. Sheiner,et al.  DifFerences in serum digoxin concentrations between outpatients and inpatients: An effect of compliance? , 1974, Clinical pharmacology and therapeutics.

[17]  R. Miller,et al.  Population pharmacokinetics of phenytoin in South African black patients. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[18]  T. Amisaki,et al.  An alternative two stage method via the EM-algorithm for the estimation of population pharmacokinetic parameters. , 1988, Journal of pharmacobio-dynamics.

[19]  B Whiting,et al.  Population Pharmacokinetic Analysis of Bisoprolol , 1989, Clinical pharmacokinetics.

[20]  A H Thomson,et al.  Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension. , 1989, British journal of clinical pharmacology.

[21]  P. Blain,et al.  Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data , 1983, Clinical pharmacokinetics.

[22]  D R Stanski,et al.  Bayesian Forecasting Improves the Prediction of Intraoperative Plasma Concentrations of Alfentanil , 1988, Anesthesiology.

[23]  D R Stanski,et al.  Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. , 1990, Anesthesiology.

[24]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[25]  L B Sheiner,et al.  Population Pharmacokinetics of Procainamide from Routine Clinical Data , 1984, Clinical pharmacokinetics.

[26]  L B Sheiner,et al.  Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.

[27]  A. Iliadis,et al.  A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients. , 1989, British Journal of Cancer.

[28]  Leon Aarons,et al.  Intravenous Phenytoin Loading in Patients after Neurosurgery and in Status Epilepticus , 1988, Clinical pharmacokinetics.

[29]  G. Mj,et al.  Effect of age and sex on theophylline clearance in young subjects. , 1982 .